Literature DB >> 22522091

Persistence of HCV in quiescent hepatic cells under conditions of an interferon-induced antiviral response.

Oliver Bauhofer1, Alessia Ruggieri, Bianca Schmid, Peter Schirmacher, Ralf Bartenschlager.   

Abstract

BACKGROUND & AIMS: Hepatitis C virus (HCV) is a common cause of chronic liver disease. Many patients do not clear the viral infection; little is known about the mechanisms of HCV persistence or the frequent failure of interferon (IFN) to eliminate it. Better culture systems are needed to study viral replication in quiescent liver cells.
METHODS: We used human hepatoma (Huh7.5) cells and those that had undergone proliferation arrest and differentiation (Huh7.5(dif)) to study the persistence of HCV infection following exposure of the cells to IFN-α and to compare the antiviral effects of IFN-α and IFN-λ. We validated these results with primary human hepatocytes and Huh7 cells that expressed an IFN-inducible fluorophore.
RESULTS: Following infection of Huh7.5(dif) cells, HCV replicated persistently and released infectious particles. Long-term exposure of the cells to IFN-α reduced HCV replication ∼1000-fold but did not eliminate the virus; viral replication rebounded after withdrawal of IFN, as it does in patients with chronic HCV infection. HCV replicated at higher levels, but not exclusively, in cells that had a low level of response to IFN-α. Following incubation of cells with equipotent concentrations of IFN-α or IFN-λ, Huh7.5(dif) cells expressed a wider pattern of IFN-stimulated genes than undifferentiated Huh7.5 cells or primary human hepatocytes, indicating that the antiviral response depends on the differentiation status of the cells.
CONCLUSIONS: We developed a cell culture system using hepatoma cells to study persistent HCV infection during the type I or type III IFN-induced antiviral response. The level and range of the antiviral responses were associated with the differentiation status of the cells. We propose that HCV exploits the stochastic nature of the response of hepatocytes to IFN to sustain persistence.
Copyright © 2012 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22522091     DOI: 10.1053/j.gastro.2012.04.018

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  26 in total

1.  Dynamic oscillation of translation and stress granule formation mark the cellular response to virus infection.

Authors:  Alessia Ruggieri; Eva Dazert; Philippe Metz; Sarah Hofmann; Jan-Philip Bergeest; Johanna Mazur; Peter Bankhead; Marie-Sophie Hiet; Stephanie Kallis; Gualtiero Alvisi; Charles E Samuel; Volker Lohmann; Lars Kaderali; Karl Rohr; Michael Frese; Georg Stoecklin; Ralf Bartenschlager
Journal:  Cell Host Microbe       Date:  2012-07-19       Impact factor: 21.023

2.  HCV infection selectively impairs type I but not type III IFN signaling.

Authors:  Partha K Chandra; Lili Bao; Kyoungsub Song; Fatma M Aboulnasr; Darren P Baker; Nathan Shores; William C Wimley; Shuanghu Liu; Curt H Hagedorn; Serge Y Fuchs; Tong Wu; Luis A Balart; Srikanta Dash
Journal:  Am J Pathol       Date:  2013-11-09       Impact factor: 4.307

Review 3.  Innate and Adaptive Immune Responses in Chronic HCV Infection.

Authors:  Lynn B Dustin
Journal:  Curr Drug Targets       Date:  2017       Impact factor: 3.465

Review 4.  Immune control and failure in HCV infection--tipping the balance.

Authors:  Lynn B Dustin; Siobhán B Cashman; Stephen M Laidlaw
Journal:  J Leukoc Biol       Date:  2014-07-11       Impact factor: 4.962

5.  Trace amounts of sporadically reappearing HCV RNA can cause infection.

Authors:  Naga Suresh Veerapu; Su-Hyung Park; Damien C Tully; Todd M Allen; Barbara Rehermann
Journal:  J Clin Invest       Date:  2014-07-08       Impact factor: 14.808

6.  Low oxygen tension enhances hepatitis C virus replication.

Authors:  N Vassilaki; K I Kalliampakou; I Kotta-Loizou; C Befani; P Liakos; G Simos; A F Mentis; A Kalliaropoulos; P P Doumba; D Smirlis; P Foka; O Bauhofer; M Poenisch; M P Windisch; M E Lee; J Koskinas; R Bartenschlager; P Mavromara
Journal:  J Virol       Date:  2012-12-26       Impact factor: 5.103

7.  In vitro systems for the study of hepatitis C virus infection.

Authors:  Garrick K Wilson; Zania Stamataki
Journal:  Int J Hepatol       Date:  2012-09-27

8.  Replication vesicles are load- and choke-points in the hepatitis C virus lifecycle.

Authors:  Marco Binder; Nurgazy Sulaimanov; Diana Clausznitzer; Manuel Schulze; Christian M Hüber; Simon M Lenz; Johannes P Schlöder; Martin Trippler; Ralf Bartenschlager; Volker Lohmann; Lars Kaderali
Journal:  PLoS Pathog       Date:  2013-08-22       Impact factor: 6.823

9.  Hepatitis C viral entry inhibitors prolong viral suppression by replication inhibitors in persistently-infected Huh7 cultures.

Authors:  Caroline O Bush; Andrew E Greenstein; William E Delaney; Rudolf K F Beran
Journal:  PLoS One       Date:  2013-06-03       Impact factor: 3.240

10.  Hepatitis C Virus-Induced Upregulation of MicroRNA miR-146a-5p in Hepatocytes Promotes Viral Infection and Deregulates Metabolic Pathways Associated with Liver Disease Pathogenesis.

Authors:  Simonetta Bandiera; Sophie Pernot; Hussein El Saghire; Sarah C Durand; Christine Thumann; Emilie Crouchet; Tao Ye; Isabel Fofana; Marine A Oudot; Jochen Barths; Catherine Schuster; Patrick Pessaux; Markus H Heim; Thomas F Baumert; Mirjam B Zeisel
Journal:  J Virol       Date:  2016-06-24       Impact factor: 6.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.